The industry considers applying automation and digitalization lessons learned during the COVID-19 pandemic to enhance workflows.
Nirupama (Rupa) Pike
Advertisement
Nirupama (Rupa) Pike, PhD, is director of Enterprise Science and Innovation Partnerships at Thermo Fisher Scientific.
Articles by Nirupama (Rupa) Pike
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial
2
RYZ101 Meets Phase 3 Primary Endpoint in Neuroendocrine Tumors After Lutetium-177 Therapy
3
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
4
FDA’s ARC Program Highlights Opportunities and Limits of Bayesian Methods in Rare Disease Trials
5